Unbiased AI-powered news
1 stories related to this topic, newest first.
theedgemarkets.comA five-day course of ensitrelvir reduced symptomatic COVID-19 cases among household contacts from 9 percent to 3 percent. The drug also lowered overall infection rates compared with placebo in a study of more than 2,000 people.